BioSpace News Archive

NUWAY®, Minnesota’s largest non-profit extended care addiction and mental healthcare treatment provider is partnering with The Center for Practice Transformation at the University of Minnesota to study the effects of recovery housing participation on addiction treatment and mental health outcomes.

Mitochon Pharmaceuticals today announced that they, in partnership with the University of Kentucky (UK) and Children’s Hospital of Philadelphia (CHOP), were awarded a $3.2M National Institutes of Health grant to study Mitochon’s mitochondrial targeted drug therapies for treating Traumatic Brain Injury (TBI).

Amphivena Therapeutics, a clinical-stage immuno-oncology company focused on developing immuno-therapeutics that restore anti-cancer immunity, today presents translational data for the lead clinical candidate from its ReSTORE (Relieve Suppression of T cells in Oncology and Reinvigorate Effectors) platform of bivalent T-cell engagers, AMV564, at the American Association for Cancer Research (AACR) 2020 Virtual Annual Meeting II.

First peer-reviewed publication highlighting Notable’s platform published today in Blood Advances

MediGO, the next-generation hardware and software platform for organ transplantation logistics, today announced its official launch into the national healthcare industry at the annual meeting of the Association for Organ Procurement Organizations (AOPO).

The Centre for Probe Development and Commercialization (CPDC) announced that its Board of Directors has appointed Justyna Kelly as Chief Executive Officer (CEO). The CEO appointment has taken effect on June 18 , 2020. Justyna Kelly was appointed the role of interim CEO in December 2019. Mark Lundie , outgoing Chair of the

FACIT, a commercialization venture firm, announced the newest recipients of Ontario First seed capital through the latest round of its Prospects Oncology Fund: Ottawa-based data science start-up Replica Analytics Ltd., and medtech innovator Dr. Greg Czarnota of Toronto’s Sunnybrook Research Institute.

ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, announced today that, pursuant to its existing, exclusive global distribution agreement with Corning Incorporated’s Life Sciences Division for its X-SERIES® product

BOX Bioscience has been at the forefront of manufacturing and distributing FDA approved and registered hand sanitizer products in response to the COVID-19 pandemic.

Biosenta Inc. listed on the CNSX is pleased to announce it is launching its disinfectant product called “True” in Canada.